NeuroVision Imaging, founded with a mission to revolutionize the early detection and monitoring of Alzheimer's Disease, focuses on developing diagnostic tests and biomarkers using advanced retinal imaging technology. The company offers a suite of tech-enabled services through its flagship telehealth platform, BrainHealth.net, which addresses gaps in the diagnostic and care pathways by screening and triaging patients for healthcare providers. NeuroVision also provides comprehensive patient journeys, including preventative neurology strategies and brain health education.

Notable affiliated individuals include leading neuroscientists and healthcare professionals who contribute to the company's innovative approach. NeuroVision has garnered significant attention from investors interested in its groundbreaking technology and potential impact on Alzheimer's diagnostics. Key achievements include the successful deployment of their retinal imaging technology in global clinical trials and the integration of machine learning algorithms for data analysis. Overall, NeuroVision's work has significantly advanced the early detection of Alzheimer's, potentially improving patient outcomes and reducing healthcare costs.